Oxford Nanopore Technologies plc (ONTTF)
OTCMKTS · Delayed Price · Currency is USD
2.125
-0.015 (-0.70%)
Oct 1, 2025, 3:40 PM EDT
ONTTF Revenue
Oxford Nanopore Technologies had revenue of 105.60M GBP in the half year ending June 30, 2025, with 22.79% growth. This brings the company's revenue in the last twelve months to 204.69M, up 22.01% year-over-year. In the year 2024, Oxford Nanopore Technologies had annual revenue of 183.19M with 7.97% growth.
Revenue (ttm)
204.69M GBP
Revenue Growth
+22.01%
P/S Ratio
7.03
Revenue / Employee
148.11K GBP
Employees
1,382
Market Cap
1.97B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 183.19M | 13.52M | 7.97% |
Dec 31, 2023 | 169.67M | -28.94M | -14.57% |
Dec 31, 2022 | 198.60M | 64.94M | 48.59% |
Dec 31, 2021 | 133.66M | 19.80M | 17.39% |
Dec 31, 2020 | 113.86M | 61.80M | 118.70% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 2.12M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Jushi Holdings | 256.36M |
Oxford Nanopore Technologies News
- 4 weeks ago - Half Year 2025 Oxford Nanopore Technologies PLC Earnings Presentation Transcript - GuruFocus
- 4 weeks ago - Oxford Nanopore Technologies plc (ONTTF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Oxford Nanopore Technologies plc 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - FTSE Falls as Starmer Resets Government - Investomania
- 4 weeks ago - UK Stock Market News: Michelmersh Brick, WizzAir, Oxford Nanopore - The Armchair Trader
- 7 weeks ago - ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology - Business Wire
- 2 months ago - FTSE 100 Breaks 9,000 as Miners Surge - Investomania
- 5 months ago - Breakthrough algorithm enables partially phased, near telomere-to-telomere assembly using standard Oxford Nanopore Simplex reads - Business Wire